Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Buchanan

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Rhode Island Medical Journal (2013)|January 26, 2022
A Comparison of National, State, and Local Drug Use Surveys: The Youth Risk Behavior Survey and the Rx for Addiction and Medication Safety ProgramEmily Patry, Ravi Upadhyay, Jeffrey Bratberg, et al.
Journal of Racial and Ethnic Health Disparities|April 20, 2021
Assessing Attitudes Toward COVID-19 Prevention: Defining Two Attitudes Crucial for Understanding Systemic and Social Variables Associated with DisparitiesAlannah Shelby Rivers, Mona Clifton, Alexandra E Pizzuto, et al.
Pharmacoepidemiology|February 6, 2023
Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United StatesTianyu Sun, Natallia Katenka, Stephen Kogut, et al.
Journal of Managed Care & Specialty Pharmacy|February 28, 2018
Estimating the Direct Costs of Outpatient Opioid Prescriptions: A Retrospective Analysis of Data from the Rhode Island Prescription Drug Monitoring ProgramHilary Aroke, Ashley Buchanan, Xuerong Wen, et al.
The American Journal of Drug and Alcohol Abuse|November 15, 2021
Early buprenorphine-naloxone initiation for opioid use disorder reduces opioid overdose, emergency room visits, and healthcare cost compared to late initiationTianyu Sun, Hilary Aroke, Stephen Kogut, et al.
Stats|June 16, 2025
Assessing Spillover Effects of Medications for Opioid Use Disorder on HIV Risk Behaviors among a Network of People Who Inject DrugsJoseph Puleo, Ashley Buchanan, Natallia Katenka, et al.
Research in Social & Administrative Pharmacy : RSAP|August 5, 2018
Rx for addiction and medication safety: An evaluation of teen education for opioid misuse preventionEmily Patry, Jeffrey P Bratberg, Ashley Buchanan, et al.
Journal of Pain & Palliative Care Pharmacotherapy|April 24, 2025
Efficacy of Low-Dose Naltrexone in Treating Patients with Fibromyalgia: systematic Review and Meta-AnalysisAbiodun Ologunowa, Marianne N Otoo, Aisling R Caffrey, et al.
Rhode Island Medical Journal (2013)|June 25, 2026
Study Design, Methods, and Modeling in Networks to Inform HIV Interventions and Policy in Marginalized PopulationsAshley Buchanan, Claire Pearsall, Stephen Kogut, et al.
Statistics in Medicine|June 8, 2022
Toward evaluation of disseminated effects of medications for opioid use disorder within provider-based clusters using routinely-collected health dataAshley Buchanan, Tianyu Sun, Jing Wu, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Rhode Island Medical Journal (2013)|January 26, 2022
A Comparison of National, State, and Local Drug Use Surveys: The Youth Risk Behavior Survey and the Rx for Addiction and Medication Safety ProgramEmily Patry, Ravi Upadhyay, Jeffrey Bratberg, et al.
Journal of Racial and Ethnic Health Disparities|April 20, 2021
Assessing Attitudes Toward COVID-19 Prevention: Defining Two Attitudes Crucial for Understanding Systemic and Social Variables Associated with DisparitiesAlannah Shelby Rivers, Mona Clifton, Alexandra E Pizzuto, et al.
Pharmacoepidemiology|February 6, 2023
Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United StatesTianyu Sun, Natallia Katenka, Stephen Kogut, et al.
Journal of Managed Care & Specialty Pharmacy|February 28, 2018
Estimating the Direct Costs of Outpatient Opioid Prescriptions: A Retrospective Analysis of Data from the Rhode Island Prescription Drug Monitoring ProgramHilary Aroke, Ashley Buchanan, Xuerong Wen, et al.
The American Journal of Drug and Alcohol Abuse|November 15, 2021
Early buprenorphine-naloxone initiation for opioid use disorder reduces opioid overdose, emergency room visits, and healthcare cost compared to late initiationTianyu Sun, Hilary Aroke, Stephen Kogut, et al.
Stats|June 16, 2025
Assessing Spillover Effects of Medications for Opioid Use Disorder on HIV Risk Behaviors among a Network of People Who Inject DrugsJoseph Puleo, Ashley Buchanan, Natallia Katenka, et al.
Research in Social & Administrative Pharmacy : RSAP|August 5, 2018
Rx for addiction and medication safety: An evaluation of teen education for opioid misuse preventionEmily Patry, Jeffrey P Bratberg, Ashley Buchanan, et al.
Journal of Pain & Palliative Care Pharmacotherapy|April 24, 2025
Efficacy of Low-Dose Naltrexone in Treating Patients with Fibromyalgia: systematic Review and Meta-AnalysisAbiodun Ologunowa, Marianne N Otoo, Aisling R Caffrey, et al.
Rhode Island Medical Journal (2013)|June 25, 2026
Study Design, Methods, and Modeling in Networks to Inform HIV Interventions and Policy in Marginalized PopulationsAshley Buchanan, Claire Pearsall, Stephen Kogut, et al.
Statistics in Medicine|June 8, 2022
Toward evaluation of disseminated effects of medications for opioid use disorder within provider-based clusters using routinely-collected health dataAshley Buchanan, Tianyu Sun, Jing Wu, et al.
Pageof 4